These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24466327)
1. Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells. Larocque K; Ovadje P; Djurdjevic S; Mehdi M; Green J; Pandey S PLoS One; 2014; 9(1):e87064. PubMed ID: 24466327 [TBL] [Abstract][Full Text] [Related]
3. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells. Kumar A; Singh B; Mahajan G; Sharma PR; Bharate SB; Mintoo MJ; Mondhe DM Tumour Biol; 2016 Oct; 37(10):13121-13136. PubMed ID: 27449046 [TBL] [Abstract][Full Text] [Related]
4. NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site. Das Mukherjee D; Kumar NM; Tantak MP; Datta S; Ghosh Dastidar D; Kumar D; Chakrabarti G Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118762. PubMed ID: 32502617 [TBL] [Abstract][Full Text] [Related]
5. Two novel series of allocolchicinoids with modified seven membered B-rings: design, synthesis, inhibition of tubulin assembly and cytotoxicity. Büttner F; Bergemann S; Guénard D; Gust R; Seitz G; Thoret S Bioorg Med Chem; 2005 May; 13(10):3497-511. PubMed ID: 15848763 [TBL] [Abstract][Full Text] [Related]
6. Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy. Bhattacharya S; Das A; Datta S; Ganguli A; Chakrabarti G Tumour Biol; 2016 Aug; 37(8):10653-64. PubMed ID: 26867767 [TBL] [Abstract][Full Text] [Related]
7. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls. Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site. Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162 [TBL] [Abstract][Full Text] [Related]
9. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells. Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540 [TBL] [Abstract][Full Text] [Related]
10. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012 [TBL] [Abstract][Full Text] [Related]
11. Novel B-ring modified allocolchicinoids of the NCME series: design, synthesis, antimicrotubule activity and cytotoxicity. Bergemann S; Brecht R; Büttner F; Guénard D; Gust R; Seitz G; Stubbs MT; Thoret S Bioorg Med Chem; 2003 Apr; 11(7):1269-81. PubMed ID: 12628654 [TBL] [Abstract][Full Text] [Related]
12. Stoichiometric and substoichiometric inhibition of tubulin self-assembly by colchicine analogues. Perez-Ramirez B; Andreu JM; Gorbunoff MJ; Timasheff SN Biochemistry; 1996 Mar; 35(10):3277-85. PubMed ID: 8605164 [TBL] [Abstract][Full Text] [Related]
13. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity. Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities. Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068 [TBL] [Abstract][Full Text] [Related]
15. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790 [TBL] [Abstract][Full Text] [Related]
16. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells. Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637 [TBL] [Abstract][Full Text] [Related]
18. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents. Klejborowska G; Urbaniak A; Preto J; Maj E; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A Bioorg Med Chem; 2019 Dec; 27(23):115144. PubMed ID: 31653441 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes. Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]